Research programmes

In i+Med we take part actively in international research consortiums

Research programmes 2017-05-05T09:43:49+00:00

Project Description

Research programmes

The research is an important pillar of our company, for this reason we look for collaborations with other research centres or companies. i+Med takes part actively in international research consortiums with research teams from universities and specialized companies to innovate in the field of smart nanotechnologies related to biomaterials development for the controlled release of active substances. These collaborations are also set up with customers to solve specific problems and satisfy their requirements.

YEAR CALL ENTITY TITLE ABSTRACT
2014 INIZIA UNIVERSITY OF THE BASQUE COUNTRY – UPV/EHU NA+HA Manufacturing of hydrogels with hyaluronic acid base as organic fluids.
2015 GAITEK BASQUE GOVERMENT HIRUGEL Development and manufacture of injectable hydrogels, which can be implanted near the are to be treated on a non- invasive way, and which are also able to release the drug in a controlled manner. The hydrogel will degrade and will finally be reabsorbed by the body.
2015 NEOTEC CDTI MIMECO NANOHIDROGELES INTELIGENTES Nanohydrogels for the controlled release of drugs, vitamins, growth factors and other compounds of interest. Within its business objectives, it intends to develop new production methods taking advantage of the technical advances to achieve a profitable level of production.
2015 INNOVA COUNCIL OF VITORIA-GASTEIZ ESTERILIZACIÓN DE NANOHIDROGELES Development and innovation in the new sterilization process for the manufacture of nanohydrogels for controlled drug release.
2016 HAZITEK BASQUE GOVERMENT HIRUGEL 2 Crosslinked nanohydrogel which acts as a vehicle for the controlled release of active agents.
2016 BIOEF BASQUE HEALTH SERVICE – OSAKIDETZA TRANSPORTADOR NANOMÉTRICO The idea is to be able to transport the tranexamic acid and the anesthetic through a gel administration that would be administered in the surgical wound before the suture in order to avoid punctures, obtaining a controlled release of the drug and a localized diffusion to the area of interest.
2016 EUROPEO EU EURONANOMED Production in a pilot plant of polymer nanostructures for bone reconstruction.
2017 HAZITEK BASQUE GOVERMENT NANOESTRUCTURAS VEHICULIZANTES DE MOLÉCULAS ACTIVAS Biodegradable nanostructures as an alternative vehicle for the administration of highly addictive drugs.